Saffron Walden, United Kingdom

Niall Anthony Gormley

This inventor holds 59 USPTO granted patents and 32 published patent applications, plus 4 CIPO patents and 21 EPO patents, primarily in Nucleic Acid Sequencing. Top assignees: Illumina Cambridge Limited, Illumina Corporation, Massachusetts Institute of Technology. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Niall Anthony Gormley. Retrieved from https://idiyas.com/inventor/niall-anthony-gormley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 59 

% Patents Active = 94.9

 

 

Average Co-Inventor Count = 3.2

ph-index = 15

Forward Citations = 1,145(Granted Patents)

Forward Citations (Not Self Cited) = 1,028(Dec 10, 2025)


Location History:

  • Nr. Saffron Walden, GB (2010 - 2016)
  • Walden, GB (2011 - 2016)
  • Little Chesterford, GB (2017)
  • Nr Saffron Walden, GB (2016 - 2020)
  • Saffron Walden, GB (2014 - 2022)
  • Essex, GB (2012 - 2024)
  • Cambridge, GB (2017 - 2024)

Company Filing History:


Years Active: 2010-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Nucleic Acid Sequencing
Library Preparation
Polynucleotide Modification
Sample Preparation
Electrophoresis
Transposome Complexes
Methylation Analysis
Surface-Based Tagmentation
Contiguity Preserving Transposition
Asymmetric Adaptors
Fragment Separation
Template Preparation
59 patents (USPTO):Explore Patents

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I can provide you with an article about inventor Niall Anthony Gormley based on the provided data.

Title: Unveiling the Innovations of Niall Anthony Gormley

Introduction:

Niall Anthony Gormley, a distinguished inventor hailing from Nr Saffron Walden, GB, has significantly contributed to the world of genomics and nucleic acid sequencing through his groundbreaking work. With an impressive portfolio of 47 patents to his name, Gormley continues to push the boundaries of scientific discovery.

Latest Patents:

Gormley's recent patents showcase his expertise in the field of genomics and nucleic acid sequencing. His innovative methods for contiguity preserving transposition and nucleic acid sequencing have revolutionized the way researchers analyze genomic variants, determine contiguity information, phase information, and methylation status of target nucleic acids.

Career Highlights:

Having worked with renowned companies such as Illumina Cambridge Limited and Illumina Corporation, Gormley has demonstrated his prowess in translating cutting-edge research into practical applications. His contributions have played a pivotal role in advancing the field of genetic analysis and sequencing technologies.

Collaborations:

Throughout his career, Gormley has collaborated with esteemed professionals in the field, including Roberto Rigatti and Jonathan Mark Boutell. These collaborations have fostered innovation and led to the development of novel techniques and methodologies in genomics and nucleic acid sequencing.

Conclusion:

In conclusion, Niall Anthony Gormley stands as a visionary inventor whose relentless pursuit of scientific excellence has left an indelible mark on the field of genomics. With a keen focus on innovation and a commitment to pushing the boundaries of scientific discovery, Gormley continues to inspire future generations of inventors and researchers.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…